🇺🇸 Placebo Capsules in United States

17 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypotension — 4 reports (23.53%)
  2. Dyspnoea — 2 reports (11.76%)
  3. Haematocrit Decreased — 2 reports (11.76%)
  4. Hypoalbuminaemia — 2 reports (11.76%)
  5. Sinus Bradycardia — 2 reports (11.76%)
  6. Abscess — 1 report (5.88%)
  7. Adverse Drug Reaction — 1 report (5.88%)
  8. Agitation — 1 report (5.88%)
  9. Alanine Aminotransferase Abnormal — 1 report (5.88%)
  10. Altered State Of Consciousness — 1 report (5.88%)

Source database →

Placebo Capsules in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Placebo Capsules approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Placebo Capsules in United States?

Repros Therapeutics Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.